Insider filing
Traded Dec 29, 2025 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 9, 2025 · Filed Dec 12, 2025
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
option exercise
Code M — exercise or conversion of a derivative security
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Insider filing
Traded Dec 29, 2025 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Insider selling
Traded Dec 29, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
A Roivant Sciences director sold $6.78M of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Dec 29, 2025 · filed 3 days later
Not classified as an open-market trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.